Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease

NCT04761952
completednot_applicable

The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial

NCT00835289
completedphase_3

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

NCT00317707
completednot_applicable

Fish Oil Supplementation in Late-life Depression

NCT01235533

Clinical Trials (4)

Showing 4 of 4 trials
NCT04761952Not Applicable

N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease

Unknown
NCT00835289Not Applicable

The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial

Completed
NCT00317707Phase 3

Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

Completed
NCT01235533Not Applicable

Fish Oil Supplementation in Late-life Depression

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4